Skip to main content

SIGN makes sense of evidence

SIGN 155: Pharmacological management of migraine - update

We’ve updated SIGN 155: Pharmacological management of migraine, to include advice on the use of oral calcitonin gene-related peptide receptor antagonists.

View the guideline:

SIGN 155: Pharmacological management of migraine

Plain language version

 

 

Guidelines for clinical practice
Guidelines for clinical practice
Guidance for patients
Guidance for patients
Methodology
Methodology
SIGN 173: Management of chronic pain (part 1)
SIGN 172: Prevention and remission of type 2 diabetes
SIGN 171: Management of diabetes in pregnancy